The Pharmafocus Interview: Jan Lundberg AstraZeneca's global head of drug discovery talks about new compounds, learning from mistakes and the real heroes behind life-saving drugs.(more)
Emerging confidence Evidence-based medicine is an evolving practice, even in the developed world, but proving value is getting tougher in emerging markets too, says Ben Shankland(more)
We can work it out Thursday , January 13, 2005
Good negotiation skills can be enormously powerful in business and life, helping you to achieve a win-win result or walk away from a bad deal, says Phil Yates. ...(more)
Building a body of evidence Monday , January 10, 2005
Getting a new drug to market is challenging enough but pharma companies then need to prove to an increasingly complex audience the benefits of their product....(more)
The weight of evidence - the stories that changed pharma in 2004 Sunday , January 09, 2005
In the year that governments faced up to the obesity epidemic and the scourge of smoking, the pharmaceutical industry was left reeling by the withdrawal of Vioxx.
Pharmafocus looks back at the highs and lows of 2004....(more)
Is the waiting over? Friday , January 07, 2005
Pharmafocus looks back at the changing NHS in 2004 - a year of renewed upheaval but real progress too.
...(more)
Zocor and the high street revolution Tuesday , January 04, 2005
The launch of the world's first OTC statin has blazed a trail - but many companies remain cautious about following the lead. Alex Wood considers the Zocor Heart-Pro story and beyond....(more)
Treading the pricing tightrope Saturday , January 01, 2005
Complex market dynamics in Europe and the US mean pricing for new products is a delicate balancing act of securing a premium price and fast market penetration....(more)
Taking the plunge Saturday , January 01, 2005
A reluctance to move outside of its 'comfort zone', rather than security issues is holding back pharma companies from fully embracing electronic data capture....(more)
